Trisenox, an injectable form of ARSENIC
November 2000
The FDA just approved Trisenox, an injectable form of ARSENIC.
Trisenox (arsenic trioxide) is for second-line therapy of acute promyelocytic leukemia. It's very effective...up to 70% remission in patients who don't do well on standard chemotherapy.
Trisenox has an interesting origin. Scientists discovered arsenic was a common ingredient in some traditional Chinese remedies for leukemia.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote